Form 4/A for GDTC CytoMed Therapeutics Ltd
Accepted 2026-07-24 21:01:08 ET · period of report 2026-07-14 · accession 0001493152-26-034654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2026-07-24 21:01 | 2026-07-14+ | GDTC | Choo Chee Kong | Dir, 10% | P - Purchase | $1.50 | +200.0K | 630.3K | +46% | +$300.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | 2026-07-14 | P | A | 100,000 | $1.50 | 530,324 | D | — | — | (F1) This Form 4/A amends the Form 4 originally filed on July 24, 2026 solely to correct the acquisition/disposition indicator in Column 4 of Table I from "D" to "A". No other changes have been made. |
| 2 | Common | ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | 2026-07-20 | P | A | 100,000 | $1.50 | 630,324 | D | — | — | (F1) This Form 4/A amends the Form 4 originally filed on July 24, 2026 solely to correct the acquisition/disposition indicator in Column 4 of Table I from "D" to "A". No other changes have been made. |